Intellia Therapeutics, Inc. (NTLA) stock
NTLANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/307% above fair value
$9.77−0.01 (-0.10%)
Close on Nov 18, 2026Market cap $1.37BP/E –Yield –
Intellia Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Intellia Therapeutics's market cap was $1.60B on Nov 11, 2026, against $1.04B a year earlier. Over the last 5 years it ranged from $711.32M to $8.79B, with a median of $2.16B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.60B | +53.5% |
| 2025 | Dec 31, 2025 | $1.04B | -12.3% |
| 2024 | Dec 31, 2024 | $1.19B | -56.3% |
| 2023 | Dec 29, 2023 | $2.72B | +1.7% |
| 2022 | Dec 30, 2022 | $2.67B | -69.6% |
| 2021 | Dec 31, 2021 | $8.79B | +174.8% |
| 2020 | Dec 31, 2020 | $3.20B | +346.0% |
| 2019 | Dec 31, 2019 | $717.03M | +21.1% |
| 2018 | Dec 31, 2018 | $591.99M | -14.6% |
| 2017 | Dec 29, 2017 | $693.56M | +47.0% |
| 2016 | Dec 30, 2016 | $471.90M | – |
See a number that looks wrong?